SE7901000L - Forfarande for framstellning av terpenoidestrar av steroider - Google Patents

Forfarande for framstellning av terpenoidestrar av steroider

Info

Publication number
SE7901000L
SE7901000L SE7901000A SE7901000A SE7901000L SE 7901000 L SE7901000 L SE 7901000L SE 7901000 A SE7901000 A SE 7901000A SE 7901000 A SE7901000 A SE 7901000A SE 7901000 L SE7901000 L SE 7901000L
Authority
SE
Sweden
Prior art keywords
strests
terpenoid
steroids
procedure
preparation
Prior art date
Application number
SE7901000A
Other languages
English (en)
Swedish (sv)
Inventor
C J Casmer
R W Draper
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of SE7901000L publication Critical patent/SE7901000L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0027Azides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0092Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0042Nitrogen only
    • C07J71/0047Nitrogen only at position 2(3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
SE7901000A 1975-02-28 1979-02-05 Forfarande for framstellning av terpenoidestrar av steroider SE7901000L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/554,351 US3984544A (en) 1975-02-28 1975-02-28 Retinoic acid esters of steroids of the pregnane series, their use in the treatment of acne and pharmaceutical formulations useful therefor

Publications (1)

Publication Number Publication Date
SE7901000L true SE7901000L (sv) 1979-02-05

Family

ID=24213007

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7602279A SE7602279L (sv) 1975-02-28 1976-02-24 Terpenoidestrar av steroider
SE7901000A SE7901000L (sv) 1975-02-28 1979-02-05 Forfarande for framstellning av terpenoidestrar av steroider

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7602279A SE7602279L (sv) 1975-02-28 1976-02-24 Terpenoidestrar av steroider

Country Status (29)

Country Link
US (1) US3984544A (xx)
JP (1) JPS51110551A (xx)
AR (1) AR218851A1 (xx)
AU (1) AU502298B2 (xx)
BE (1) BE838923A (xx)
CA (1) CA1064905A (xx)
CH (1) CH629825A5 (xx)
CS (1) CS195722B2 (xx)
DD (1) DD125593A5 (xx)
DE (1) DE2607418A1 (xx)
DK (1) DK142201B (xx)
ES (1) ES445488A1 (xx)
FI (1) FI760472A (xx)
FR (1) FR2302099A1 (xx)
GB (1) GB1533614A (xx)
GR (1) GR59913B (xx)
HK (1) HK7082A (xx)
HU (1) HU176716B (xx)
IE (1) IE43452B1 (xx)
IL (1) IL49103A (xx)
KE (1) KE3189A (xx)
LU (1) LU74421A1 (xx)
NL (1) NL7601864A (xx)
NO (1) NO760607L (xx)
NZ (1) NZ180110A (xx)
PH (1) PH13213A (xx)
PT (1) PT64835B (xx)
SE (2) SE7602279L (xx)
ZA (1) ZA761128B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843096A (en) * 1985-06-26 1989-06-27 Stiefel Laboratories, Inc. Treatment of acne
US4885311A (en) * 1987-06-29 1989-12-05 Molecular Design International Topical transretinoids for treatment of acne and skin diseases
FR2644459B1 (fr) * 1989-03-16 1994-10-28 Oreal Esters retinoiques de l-cladinose, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
US5648563A (en) * 1991-04-09 1997-07-15 Sloan-Kettering Institute For Cancer Research Retro-alpha-retinol derivative and uses of retro-alpha-retinol
US6506917B1 (en) * 1991-12-18 2003-01-14 The Salk Institute For Biological Studies Compounds and compositions useful for modulation of processes mediated by RXR
US7056954B2 (en) * 1991-12-18 2006-06-06 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
FR2761600B1 (fr) * 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
JP2005020400A (ja) * 2003-06-26 2005-01-20 Hitachi Communication Technologies Ltd 無線基地局、無線通信システム、無線基地局の通信制御方法、および、無線通信網の構築方法
US7126017B2 (en) * 2003-01-17 2006-10-24 Wisconsin Alumni Research Foundation Method of reducing toxicity of retinoids
AU2004206900B2 (en) 2003-01-17 2011-03-10 Wisconsin Alumni Research Foundation Modified retinoid compounds and their uses
US20080139518A1 (en) * 2006-12-04 2008-06-12 Concert, Llc Topical compositions for treatment of skin conditions
US20090203628A1 (en) * 2008-02-12 2009-08-13 Jan Marini Composition, Method And Kit For Treating Skin Disorders And Improving Skin Condition
UA116622C2 (uk) 2011-11-11 2018-04-25 Аллерган, Інк. Похідні 4-прегенен-11ss-17-21-тріол-3,20-діону для лікування хвороб очей

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1530972A (fr) * 1966-07-15 1968-06-28 Angeli Inst Spa Procédé de préparation d'esters de stéroïde
US3780177A (en) * 1967-06-16 1973-12-18 Warner Lambert Co 17-butyrate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use

Also Published As

Publication number Publication date
AR218851A1 (es) 1980-07-15
FR2302099B1 (xx) 1978-11-10
ZA761128B (en) 1977-02-23
IL49103A (en) 1979-12-30
SE7602279L (sv) 1976-08-30
ES445488A1 (es) 1977-11-01
IL49103A0 (en) 1976-04-30
PT64835B (en) 1977-06-07
CS195722B2 (en) 1980-02-29
IE43452L (en) 1976-08-28
KE3189A (en) 1982-04-02
NZ180110A (en) 1978-06-20
AU502298B2 (en) 1979-07-19
IE43452B1 (en) 1981-02-25
HK7082A (en) 1982-02-26
GR59913B (en) 1978-03-20
PT64835A (en) 1976-03-01
JPS51110551A (xx) 1976-09-30
US3984544A (en) 1976-10-05
NL7601864A (nl) 1976-08-31
FI760472A (xx) 1976-08-29
DK142201B (da) 1980-09-22
PH13213A (en) 1980-02-07
DD125593A5 (xx) 1977-05-04
DE2607418A1 (de) 1976-09-09
DK79976A (xx) 1976-08-29
DK142201C (xx) 1981-03-02
GB1533614A (en) 1978-11-29
LU74421A1 (xx) 1977-01-07
NO760607L (xx) 1976-08-31
BE838923A (fr) 1976-08-25
CA1064905A (en) 1979-10-23
HU176716B (en) 1981-04-28
AU1142076A (en) 1977-09-01
FR2302099A1 (fr) 1976-09-24
CH629825A5 (de) 1982-05-14

Similar Documents

Publication Publication Date Title
SE433208B (sv) Forfarande for framstellning av fenoletrar
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
SE7513085L (sv) Forfarande for framstellning av etrar
IT1063150B (it) Steroidi e procedimento per la loro preparazione
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE7901000L (sv) Forfarande for framstellning av terpenoidestrar av steroider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE433937B (sv) Forfarande for framstellning av penicillinestrar
SE431642B (sv) Forfarande for framstellning av bestatin-foreningar
SE7611280L (sv) Forfarande for framstellning av 3-hydroxi-3-cefemestersulfoxider
NO792651L (no) Fremgangsmaate for fremstilling av spesielle steroider
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE7600910L (sv) Forfarande for framstellning av polyuretaner
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE423814B (sv) Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
SE7508654L (sv) Forfarande for framstellning av steroider